| Primary |
| Non-hodgkin's Lymphoma |
64.3% |
| Hepatitis C |
14.3% |
| Schizophrenia |
14.3% |
| Drug Use For Unknown Indication |
7.1% |
|
| Neutropenia |
33.3% |
| White Blood Cell Count Decreased |
33.3% |
| White Blood Cell Count Increased |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
41.3% |
| Schizophrenia |
14.7% |
| Drug Use For Unknown Indication |
14.1% |
| Depression |
3.2% |
| Non-hodgkin's Lymphoma Unspecified Histology Aggressive |
3.2% |
| Hypertension |
2.3% |
| Insomnia |
2.2% |
| Anxiety |
2.1% |
| Hepatitis C |
2.0% |
| Psychotic Disorder |
2.0% |
| Salivary Hypersecretion |
2.0% |
| Extrapyramidal Disorder |
1.8% |
| Dyspepsia |
1.6% |
| Depressed Mood |
1.4% |
| Schizophrenia, Paranoid Type |
1.4% |
| Convulsion |
1.2% |
| Diffuse Large B-cell Lymphoma |
1.1% |
| Hypercholesterolaemia |
1.0% |
| Diabetes Mellitus |
0.8% |
| B-cell Lymphoma |
0.7% |
|
| Overdose |
12.4% |
| White Blood Cell Count Decreased |
12.4% |
| Protein Total Decreased |
11.6% |
| Toxicity To Various Agents |
5.8% |
| Viral Infection |
5.4% |
| Neutropenia |
5.0% |
| Renal Failure Acute |
5.0% |
| Unresponsive To Stimuli |
5.0% |
| Vomiting |
5.0% |
| Thrombocytopenia |
4.6% |
| White Blood Cell Count Increased |
4.1% |
| Sedation |
3.7% |
| Treatment Noncompliance |
3.3% |
| Drug Interaction |
2.9% |
| Ventricular Hypertrophy |
2.9% |
| Loss Of Consciousness |
2.5% |
| Drug Level Increased |
2.1% |
| Intentional Overdose |
2.1% |
| Respiratory Depression |
2.1% |
| Tachycardia |
2.1% |
|
| Concomitant |
| Asthma |
21.7% |
| Drug Use For Unknown Indication |
13.0% |
| Schizophrenia |
12.0% |
| Dyspnoea |
6.5% |
| Non-small Cell Lung Cancer |
6.5% |
| Depression |
5.4% |
| Osteoporosis |
5.4% |
| Constipation |
4.3% |
| Prophylaxis |
4.3% |
| Affective Disorder |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Endometriosis |
2.2% |
| Hypothyroidism |
2.2% |
| Menstrual Cycle Management |
2.2% |
| Psychotic Disorder |
2.2% |
| Sleep Disorder |
2.2% |
| Stress |
2.2% |
| Anaemia |
1.1% |
| Anti-infective Therapy |
1.1% |
| Anxiety |
1.1% |
|
| White Blood Cell Count Decreased |
15.2% |
| Drug Interaction |
6.1% |
| Dyspnoea |
6.1% |
| Pneumonia |
6.1% |
| Pulmonary Haemorrhage |
6.1% |
| Respiratory Depression |
6.1% |
| Sedation |
6.1% |
| Tachycardia |
6.1% |
| Viral Infection |
6.1% |
| White Blood Cell Count Increased |
6.1% |
| Asthma |
3.0% |
| Chest Pain |
3.0% |
| Deep Vein Thrombosis |
3.0% |
| Ear, Nose And Throat Examination Abnormal |
3.0% |
| Eye Pain |
3.0% |
| Fall |
3.0% |
| Glossodynia |
3.0% |
| Muscle Spasms |
3.0% |
| Oral Pain |
3.0% |
| Overdose |
3.0% |
|
| Interacting |
| Non-hodgkin's Lymphoma Unspecified Histology Aggressive |
25.0% |
| Product Used For Unknown Indication |
8.3% |
| Abdominal Pain Upper |
5.6% |
| Anxiety |
5.6% |
| Back Pain |
5.6% |
| Constipation |
5.6% |
| Depressed Mood |
5.6% |
| Drug Use For Unknown Indication |
5.6% |
| Extrapyramidal Disorder |
5.6% |
| Insomnia |
5.6% |
| Salivary Hypersecretion |
5.6% |
| Schizophrenia |
5.6% |
| Breast Cancer |
2.8% |
| Ill-defined Disorder |
2.8% |
| Bipolar Disorder |
1.4% |
| Contraception |
1.4% |
| Diabetes Mellitus |
1.4% |
| Urinary Incontinence |
1.4% |
|
| Toxicity To Various Agents |
28.6% |
| Leukopenia |
14.3% |
| Renal Failure Acute |
14.3% |
| White Blood Cell Count Decreased |
14.3% |
| Drug Interaction |
7.1% |
| Hypotension |
7.1% |
| Neutropenia |
7.1% |
| Orthostatic Hypotension |
7.1% |
|
